VYRO
Vyro is a biotechnology company focused on developing cancer-killing, or "oncolytic", viruses (OVs) designed to target adult and pediatric central nervous system (CNS) tumors.
Founded by scientists from The Human Genome and Stem Cell Research Center (HUG-CELL) of the Institute of Biosciences of the University of São Paulo, based on pioneering research on the oncolytic properties of the Zika Virus (ZIKV).
CNS ADULT TUMORS: A HUGE UNMET MEDICAL NEED
How common is this cancer?
CNS PEDIATRIC TUMORS
Brain cancer has surpassed leukemia as the deadliest form of childhood cancer, which is the No. 1 disease-related killer of children under 15.
Despite this, there has never been a drug developed and approved specifically for malignant pediatric brain tumors.
National Cancer Institute
.png)